Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIMDW
Ainos
$0.11
+8.1%
$0.12
$0.03
$0.37
N/AN/A18,737 shs19,655 shs
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
$13.50
$16.14
$3.00
$95.04
N/AN/A2,005 shs2 shs
DHAIW
DIH Holding US
$0.01
+0.8%
$0.01
$0.01
$0.13
N/AN/A139,714 shs75,509 shs
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
$2.62
$2.11
$7.17
$3.92M0.319,658 shs28,800 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIMDW
Ainos
+8.06%-12.31%-13.77%-36.06%+67.40%
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00%0.00%0.00%-33.17%-67.56%
DHAIW
DIH Holding US
+8.20%+12.82%+1.54%-13.73%-71.30%
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIMDW
Ainos
N/AN/AN/AN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/AN/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIMDW
Ainos
0.00
N/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00
N/AN/AN/A
DHAIW
DIH Holding US
0.00
N/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIMDW
Ainos
$106.21KN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/A
DHAIW
DIH Holding US
$64.47MN/AN/AN/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
$91.86M0.00N/AN/A$51.82 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIMDW
Ainos
N/AN/A0.00N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/A0.00N/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/A0.00N/AN/AN/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
-$9.81MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIMDW
Ainos
N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
DHAIW
DIH Holding US
N/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
0.26%

Insider Ownership

CompanyInsider Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
DHAIW
DIH Holding US
N/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
2.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
AIMDW
Ainos
40N/AN/ANot Optionable
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
2N/AN/ANot Optionable
DHAIW
DIH Holding US
N/AN/AN/AN/A
Xylo Technologies Ltd stock logo
MDGS
Xylo Technologies
771.66 million1.62 millionOptionable

Recent News About These Companies

Xylo Technologies Offers Pre-Funded Warrant for ADSs

Media Sentiment Over Time

Ainos NASDAQ:AIMDW

$0.11 +0.01 (+8.06%)
As of 06/11/2025 03:31 PM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLGW

$13.50 0.00 (0.00%)
As of 06/11/2025

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

DIH Holding US NASDAQ:DHAIW

$0.01 +0.00 (+0.76%)
As of 02:53 PM Eastern

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Xylo Technologies stock logo

Xylo Technologies NASDAQ:MDGS

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.